Spectral Libraries are Key for Confident Compound Identification

In metabolomics, confident compound identification is still a major difficulty. While efforts are in progress to improve the definitions and levels of metabolite identifications that were initially proposed by the MSI initiative,^[1-4] it is evident that higher levels of confidence can be achieved by integrating orthogonal molecular features, sophisticated software tools, and exact measurement technology.

In this article, a single integrated software solution is presented for improving the confidence in identifications at various levels: structure, compound class, molecular formula, or verified targeted identification (Figure 1). This highly integrated functionality is applied to the innovative MetaboScape^® 2.0 software.

Figure 1. In MetaboScape 2.0, compound identification is supported by a variety of (semi-)automated tools, which are highly integrated and enable the creation of annotations at increasing levels of specificity and confidence.

Molecular Formulas

Conventionally, molecular formulas are created on the basis of a single precursor mass, using a limited number of elements (usually CHNOPS) and the signified mass tolerance. Smart-Formula^TM enables further consideration of previous knowledge and other properties:

• “Golden Rules”^[5]
  • Senior and Lewis rule
  • Element ratios
  • Upper formula
  • Element count probability
• In-source fragmentation
• True Isotopic Pattern^TM (TIP)

SmartFormula 3D offers a smart interface enabling users to annotate all monoisotopic peaks of an MS/MS spectrum using fragment formulas (see Figure 2).

Figure 2. An example MS/MS spectrum of gamma-glutamyl valine in SmartFormula 3D, highlighting characteristic fragments corresponding to the losses of NH₃ and CH₅NO₂. These are indicators for gamma-glutamyl dipeptides rather than alpha-glutamyl dipeptides.^[8]

Structural Candidates Search

The CompoundCrawler^TM tool available within MetaboScape can be used to obtain candidate structures of molecular formulas that are created previously. This tool queries a customizable type of public or private structural databases, including PubChem, KEGG, ChEBI, and ChemSpider. After that, identical structures can be evaluated using in-silico fragmentation.

MetFrag In-Silico Fragmentation

The MetFrag^{[6, 7]} in-silico MS/MS fragmentation algorithm is incorporated into MetaboScape 2.0 and can be used to evaluate and score structural candidates from CompoundCrawler search results to obtained MS/MS spectral information. As shown in Figure 3, explained fragments are highlighted in the original compound structure.

Figure 3. Screenshot of a MetFrag result in MetaboScape. For the precursor, 182.0811 m/z SmartFormula generated three possible molecular formulas. Structural candidates for these were determined using CompoundCrawler (PubChem and custom MetaboScape AnalyteDB). For Tyrosine, 97.52% of the MS/MS intensity could be covered with explained fragments. The annotation was confirmed by an excellent Spectral Library (Bruker HMDB Metabolite Library) match and could be explained in SmartFormula 3D.

MS/MS Spectral Libraries

Users can generate or import MS/MS spectral libraries. After that, these can be used to annotate compounds, if the spectral similarity fulfills the user-defined thresholds. An interactive spectral library editor is incorporated into the innovative Metabo-Scape 2.0 software.

Targeted Analyte Lists

Analyte Lists are used to easily annotate the compounds with known retention times. If necessary, compounds can be associated with the entries of spectral libraries, so as to include MS/MS spectral matching. Consequently, Analyte Lists enable the integration of MS/MS, RT, and MS information for confident dereplication.

Conclusions

• The software has a comprehensive set of tools for performing compound annotation at all specificity levels
• For boosting confidence in compound ID, true isotopic pattern, HRAM, retention time, and MS/MS fragmentation are integrated
• All tools are combined to create application-specific workflows:
  • CompoundCrawler embedded
  • MS/MS spectral libraries matching and management
  • MetFrag embedded
  • SmartFormula 3D embedded
  • AnalyteLists for targeted compound identification

Acknowledgements

Produced from materials originally authored by Nikolas Kessler; Heiko Neuweger; Verena Tellström, Aiko Barsch from Bruker Daltonik GmbH, Bremen, Germany

References

[1] Fiehn et al.; Metabolomics 2007, 3:175–178.

[2] Sumner et al.; Metabolomics 2007, 3:211–221.

[3] Sumner et al.; Metabolomics 2014, 6:1047–1049.

[4] Schymanski et al.; Environ. Sci. Technol. 2014, 48:2097−2098.

[5] Kind and Fiehn; BMC Bioinformatics 2007, 8:105.

[6] Wolf et al.; BMC Bioinformatics 2010, 11:148.

[7] Ruttkies et al.; J. Cheminf. 2016, 8:3.

[8] Harrison; J Mass Spectrom. 2013, 38:174–187.

About Bruker Daltonics

Empowering Science – Improving Life

Bruker Daltonics delivers cutting-edge mass spectrometry solutions and workflows that help scientists and industry leaders tackle real-world challenges and make new discoveries. From life sciences and pharmaceutical research to food and contaminant analysis, environmental monitoring, forensics, and industrial quality control, our technologies and instruments provide the precision and reliability you need to make confident decisions.

Our innovative platforms - such as timsTOF, scimaX, neofleX, and DART-TQ - combined with advanced software like SCiLS^™ Lab, MetaboScape^®, and Biopharma Compass^®, transform complex data into actionable insights. Breakthrough innovations like Trapped Ion Mobility (TIMS), Omnitrap^®, and dual ionization GC-HRMS are redefining what’s possible in mass spectrometry.

Trusted by leading research institutes, universities, government agencies, and industrial partners worldwide, Bruker Daltonics is committed to driving scientific progress and delivering solutions that matter.

(For Research Use Only. Not for use in clinical diagnostic procedures).

Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.